CUFinder

Zahra Reynolds

Zahra Reynolds

Harvard University

H-index: 12

North America-United States

Contact Zahra Reynolds

About Zahra Reynolds

Zahra Reynolds, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at Harvard University, specializes in the field of HIV, public health.

His recent articles reflect a diverse array of research interests and contributions to the field:

HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal, South Africa: A population-based study

HIV, Social Networks, and Loneliness among Older Adults in Uganda

SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency

SARS-CoV-2 virologic rebound with nirmatrelvir–ritonavir therapy: an observational study

The benefits of care: treated HIV infection and health-related quality of life among older-aged people in Uganda

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy

Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for coronavirus disease 2019 (COVID-19)

Associations of the COVID-19 pandemic with quality of life: A cross-sectional study of older-age people with and without HIV in rural Uganda

Zahra Reynolds Information

University

Position

Massachusetts General Hospital

Citations(all)

679

Citations(since 2020)

678

Cited By

99

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

14

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Zahra Reynolds Skills & Research Interests

HIV

public health

Top articles of Zahra Reynolds

HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal, South Africa: A population-based study

Plos one

2024/2/21

Zahra Reynolds
Zahra Reynolds

H-Index: 4

HIV, Social Networks, and Loneliness among Older Adults in Uganda

AIDS and Behavior

2024/1/28

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Yao Tong
Yao Tong

H-Index: 1

Deanna Saylor
Deanna Saylor

H-Index: 16

SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency

Science Translational Medicine

2024/1/24

Yijia Li
Yijia Li

H-Index: 2

Anusha Nathan
Anusha Nathan

H-Index: 3

Yumeko Kawano
Yumeko Kawano

H-Index: 3

Rinki Deo
Rinki Deo

H-Index: 6

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Gaurav D Gaiha
Gaurav D Gaiha

H-Index: 11

Jonathan Z Li
Jonathan Z Li

H-Index: 35

SARS-CoV-2 virologic rebound with nirmatrelvir–ritonavir therapy: an observational study

Annals of Internal Medicine

2023/12

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Yijia Li
Yijia Li

H-Index: 2

Yumeko Kawano
Yumeko Kawano

H-Index: 3

Jonathan Z Li
Jonathan Z Li

H-Index: 35

The benefits of care: treated HIV infection and health-related quality of life among older-aged people in Uganda

Aging & MentAl HeAltH

2023/9/2

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Yao Tong
Yao Tong

H-Index: 1

Deanna Saylor
Deanna Saylor

H-Index: 16

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy

2023

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Yijia Li
Yijia Li

H-Index: 2

Yumeko Kawano
Yumeko Kawano

H-Index: 3

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for coronavirus disease 2019 (COVID-19)

Clinical Infectious Diseases

2023/2/1

Arshdeep Singh
Arshdeep Singh

H-Index: 2

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Associations of the COVID-19 pandemic with quality of life: A cross-sectional study of older-age people with and without HIV in rural Uganda

Journal of global health

2023

Yao Tong
Yao Tong

H-Index: 1

Deanna Saylor
Deanna Saylor

H-Index: 16

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Christine Ritchie
Christine Ritchie

H-Index: 45

Duration of viable virus shedding in SARS-CoV-2 omicron variant infection

MedRXiv

2022/3/2

Arshdeep Singh
Arshdeep Singh

H-Index: 2

Yijia Li
Yijia Li

H-Index: 2

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Virologic characterization of symptom rebound following nirmatrelvir-ritonavir treatment for COVID-19 (preprint)

Clinical Infectious Diseases

2023/2/1

Arshdeep Singh
Arshdeep Singh

H-Index: 2

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections

JCI insight

2022/1/1

Sebastien Haneuse
Sebastien Haneuse

H-Index: 35

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Robert H Goldstein
Robert H Goldstein

H-Index: 5

Crystal M North
Crystal M North

H-Index: 9

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Effects of the COVID-19 pandemic on quality of life for older Ugandans with and without HIV

APHA 2022 Annual Meeting and Expo

2022/11/8

Deanna Saylor
Deanna Saylor

H-Index: 16

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Rebecca Gilbert
Rebecca Gilbert

H-Index: 4

Christine Ritchie
Christine Ritchie

H-Index: 45

Antiretroviral therapy adherence patterns, virological suppression, and emergence of drug resistance: A nested case–control study from Uganda and South Africa

Antiviral Therapy

2022/10/20

Yao Tong
Yao Tong

H-Index: 1

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Tulio De Oliveira
Tulio De Oliveira

H-Index: 34

Richard Lessells
Richard Lessells

H-Index: 25

Catherine Orrell
Catherine Orrell

H-Index: 29

Jessica E Haberer
Jessica E Haberer

H-Index: 48

Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant

JCI insight

2022/10/10

Arshdeep Singh
Arshdeep Singh

H-Index: 2

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Jeremy Luban
Jeremy Luban

H-Index: 40

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Priorities for health and wellbeing for older people with and without HIV in Uganda: a qualitative methods study

Journal of the International AIDS Society

2022/9

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Rebecca Gilbert
Rebecca Gilbert

H-Index: 4

Deanna Saylor
Deanna Saylor

H-Index: 16

Lien Quach
Lien Quach

H-Index: 14

Duration of shedding of culturable virus in SARS-CoV-2 Omicron (BA. 1) infection

New England Journal of Medicine

2022/7/21

Arshdeep Singh
Arshdeep Singh

H-Index: 2

Yijia Li
Yijia Li

H-Index: 2

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Who’s slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first‐line HIV treatment in …

HIV medicine

2022/5

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Brent A Johnson
Brent A Johnson

H-Index: 24

Determining the incidence of asymptomatic SARS-CoV-2 among early recipients of COVID-19 vaccines (DISCOVER-COVID-19): a prospective cohort study of healthcare workers before …

Clinical Infectious Diseases

2022/4/1

Crystal M North
Crystal M North

H-Index: 9

Robert H Goldstein
Robert H Goldstein

H-Index: 5

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Karl Laskowski
Karl Laskowski

H-Index: 6

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Vaccine breakthrough infection with the SARS-CoV-2 Delta or Omicron (BA. 1) Variant leads to distinct profiles of neutralizing antibody responses

medRxiv

2022/3/3

Arshdeep Singh
Arshdeep Singh

H-Index: 2

Zahra Reynolds
Zahra Reynolds

H-Index: 4

Jeremy Luban
Jeremy Luban

H-Index: 40

Jonathan Z Li
Jonathan Z Li

H-Index: 35

Increasing men’s engagement in HIV testing and treatment programs through crowdsourcing: a mixed-methods analysis in Eswatini

Sexually transmitted diseases

2021/10/1

Zahra Reynolds
Zahra Reynolds

H-Index: 4

See List of Professors in Zahra Reynolds University(Harvard University)